Thanksgiving Deal Recombinant Rat Her2/erbb2 Protein (aa 67-323, His Tag) - Today Only [t1jL0vIH]

Thanksgiving Deal Recombinant Rat Her2/erbb2 Protein (aa 67-323, His Tag) - Today Only [t1jL0vIH]

Introducing our high-quality Recombinant Rat HER2/ErbB2 Protein, a critical component in the study of cell proliferation and differentiation. This recombinant protein is derived from rat sources and spans amino acids 67 to 323, providing a precise and controlled research tool for researchers in the field of oncology and cellular biology. The protein is fused with a His Tag, facilitating ease of use and compatibility with various biochemical techniques.

Properties and Specifications

Our Recombinant Rat HER2/ErbB2 Protein is produced in E. coli and undergoes rigorous quality control to ensure high purity, exceeding 95% as determined by reducing SDS-PAGE. The observed molecular weight is 32 kDa, with a calculated molecular weight of 29.3 kDa. This protein is well-suited for a variety of applications, including Western blotting, immunoprecipitation, and enzyme-linked immunosorbent assays. Key specifications include:

Expression Host: E. coli

Sequence: Ala67-Val323

Tag: C-His

Applications and Benefits

This Recombinant Rat HER2/ErbB2 Protein is ideal for research into various cancers, particularly breast, prostate, and ovarian cancers, where HER2/ErbB2 overexpression is a hallmark. It plays a crucial role in the signaling pathways involving mitogen-activated protein kinase and phosphatidylinositol-3 kinase, making it essential for understanding cell growth and differentiation. With its superior purity, low endotoxin level, and convenient storage conditions, this protein is a valuable addition to any researcher's toolkit. It is particularly beneficial for:

Exploring the role of HER2/ErbB2 in cancer development and progression

Developing targeted therapies for cancer treatment

Assessing cellular signaling and proliferation in vitro

Embrace the power of our Recombinant Rat HER2/ErbB2 Protein to advance your research and make significant breakthroughs in the field of oncology and cellular biology.